IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?. (2019). Mediterranean Journal of Hematology and Infectious Diseases, 11(1), e2019063. https://doi.org/10.4084/mjhid.2019.063